CD117 (c-kit) is a restricted antigen of acute myeloid leukemia and characterizes early differentiative levels of M5 FAB subtype

Haematologica

Volumn 83, Issue 5, 1998, Pages 392-397

  Cascavilla, Nicola ^a   Musto, Pellegrino ^a   D'Arena, Giovanni ^a   Melillo, Lorella ^a   Carella, Angelo Michele ^a   Petrilli, Maria Pia ^a   Sanpaolo, Grazia ^a   Carotenuto, Mario ^a  

^a CASA SOLLIEVO DELLA SOFFERENZA HOSPITAL   (Italy)

Author keywords

ALL; AML; CD117

Indexed keywords

CD11B ANTIGEN; CD14 ANTIGEN; CD15 ANTIGEN; CD4 ANTIGEN; CD45 ANTIGEN; CD7 ANTIGEN; GLYCOPROTEIN P 15095; STEM CELL FACTOR RECEPTOR;

ACUTE GRANULOCYTIC LEUKEMIA; ADOLESCENT; ADULT; AGED; ANTIGEN EXPRESSION; ARTICLE; CANCER CLASSIFICATION; CELL DIFFERENTIATION; CELL LINEAGE; CHILD; CONTROLLED STUDY; FEMALE; FLOW CYTOMETRY; HUMAN; HUMAN CELL; MAJOR CLINICAL STUDY; MALE; SCHOOL CHILD;

ACUTE DISEASE; ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANTIGENS, NEOPLASM; CELL DIFFERENTIATION; CHILD; FEMALE; HUMANS; IMMUNOGLOBULIN FAB FRAGMENTS; LEUKEMIA, MYELOID; MALE; MIDDLE AGED; PROTO-ONCOGENE PROTEINS C-KIT;

EID: 0031807833     PISSN: 03906078     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (35)

1. Yarden Y, Kuang WJ, Yang-Feng T, et al. Human proto-oncogene c-kit: a new cell surface receptor tyrosine kinase for an unidentified ligand. EMBO J 1987; 6:3341-51.
2. Broxmeyer HE, Cooper S, Lu L, et al. Effect of murine mast cell growth factor (c-kit proto-oncogene ligand) on colony formation by human bone marrow hematopoietic progenitor cells. Blood 1991; 77:2142-9.
3. Pietsch T, Kyas U, Steffens U, et al. Effects of human stem cell factor (c-kit ligand) on proliferation of myeloid leukemia cells: heterogeneity in response to synergy with other hematopoietic growth factors. Blood 1992; 80:1199-206.
4. Broudy VC. Stem cell factor and hematopoiesis. Blood 1997; 90:1345-64.
5. Strobl H, Takimoto M, Majdic O, Hocker P, Knapp W. Antigenic analysis of human haematopoietic progenitor cells expressing the growth factor receptor c-kit. Br J Haematol 1992; 82:287-94.
6. D'Arena G, Cascavilla N, Musto P, et al. Flow cytometric characterization of CD34+ hematopoietic progenitor cells in mobilized peripheral blood and bone marrow of cancer patients. Haematologica 1996; 81:216-23.
7. Buhring HJ, Ulrich A, Schaudt K, Muller CA, Busch FW. The product of the proto-oncogene c-kit is a human bone marrow surface antigen of hemopoietic precursor cells which is expressed on a subset of acute non-lymphoblastic leukemic cells. Leukemia 1991; 5: 854-60.
8. Di Noto R, Lo Pardo C, Schiavone EM, et al. Stem cell factor receptor (c-kit, CD117) is expressed on blast cells from most immature types of acute myeloid malignancies but is also a characteristic of a subset of acute promyelocytic leukemia. Br J Haematol 1996; 92:562-4.
9. Matutes E, Rodriguez-Valverde L, Farahat N, et al. C-kit receptor (CD117) expression in acute leukemia [abstract]. Blood 1995; 86(Suppl 1):770a.
10. Lauria F, Bagnara GP, Rondelli D, et al. Cytofluorimetric and functional analysis of c-kit receptor in acute leukemia. Leuk Lymphoma 1995; 18:451-5.
11. Kubota A, Okamura S, Shimoda k, Harada M, Niho Y. The c-kit molecule and the surface immunophenotype of human acute leukemia. Leuk Lymphoma 1994; 14:421-8.
12. Sperling C, Schwartz S, Bûchner T, Thiel E, Ludwig WD. Expression of the stem cell factor receptor c-kit (CD117) in acute leukemias. Haematologica 1997; 82:617-21.
13. Muroi K, Nakamura M, Amemiya Y, Suda T, Miura Y. Expression of c-kit receptor (CD117) and CD34 in leukemic cells. Leuk Lymphoma 1995; 16:297-305.
14. Lanza F, Moretti S, Castagnari B, Latorraca A, Ferrari L, Castoldi GL. Flow cytometry quantitation of II-3 and c-kit receptors in acute leukemias. Clinical and biological implications [abstract]. Haematologica 1996; 81(suppl 5):80.
15. Macedo A, Orfao A, Martinez A, et al. Immunophenotype of c-kit cells in normal human bone marrow: implications for the detection of minimal residual disease in AML. Br J Haematol 1995; 89:338-41.
16. Reuss-Borst MA, Buhring HJ, Schmidt H, Muller CA. AML: immunophenotypic heterogeneity and prognostic significance of c-kit expression. Leukemia 1994; 8:258-63.
17. Sperling C, Schwartz S, Maurer J, et al. CD117 expression is restricted to myeloid and early T-lineage differentiation in acute leukemias and lacks prognostic significance in AML [abstract]. Blood 1995; 86(suppl. 1):40a.
18. Ikeda H, Kanakura Y, Tamaki T, et al. Expression and functional role of the proto-oncogene c-kit in acute myeloblastic leukemia cells. Blood 1991; 78:2962-8.
19. Nishii K, Kita K, Miwa H, et al. C-kit gene expression in CD7 positive acute lymphoblastic leukemia: close correlation with expression of myeloid associated antigen CD13. Leukemia 1992; 6:662-8.
20. Bennett JM, Catovsky D, Daniel MT, et al. Proposed revised criteria for the classification of acute myeloid leukemia. Ann Intern Med 1985; 103:620-5.
21. Cascavilla N, Greco MM, Ladogana S, et al. Acute myeloid leukemia: correlation between FAB classification criteria and surface antigenic markers. Haematologica 1988; 73:37-42.
22. Foon KA, Todd RF. Immunologic classification of leukemia and lymphoma. Blood 1986; 68:1-31.
23. Cascavilla N, Musto P, D'Arena G, et al. Are "early" and "late" T acute lymphoblastic leukemias different diseases? A single center study of 34 patients. Leuk Lymphoma 1996; 21:437-42.
24. Armitage P. Statistical methods in medical research. New York: John Wiley & Sons, 1971.
25. Carlo Stella C. Cazzola M, De Fabritiis P, et al. CD34 positive cells: biology and clinical relevance. Haematologica 1995; 80:367-87.
26. Cascavilla N, Musto P, D'Arena G, Ladogana S, Matera R, Carotenuto M. Adult and childhood acute lymphoblastic leukemia: clinico-biological differences based on CD34 antigen expression. Haematologica 1997; 82:31-7.
27. Vinante F, Pizzolo G, Rigo A, et al. The CD4 molecule belongs to the phenotypic repertoire of most cases of acute myeloid leukemia. Leukemia 1992; 6:1257-62.
28. Griffin JD, Löwemberg B. Clonogenic cells in acute myeloblastic leukemia. Blood 1986; 68: 1185-95.
29. Cuneo A, Ferrant A, Michaux JL, et al. Philadelphia chromosome-positive acute myeloid leukemia: cytoimmunologic and cytogenetic features. Haematologica 1996; 81:423-7.
30. Muroi K, Amemiya Y, Miura Y. Specificity of CD117 expression in the diagnosis of acute myeloid leukemia. Leukemia 1996; 10:1048.
31. Godfrey DI, Zlotnik A, Suda T. Phenotypic and functional characterization of c-kit expression during intrathymic T cell development. J Immunol 1992; 149:2281-5.
32. deCastro CM, Denning SM, Langdon S, et al. The c-kit proto-oncogene receptor is expressed on a subset of human CD3-CD4-CD8- (triple-negative) thymocytes. Exp Hematol 1994; 22:1025-33.
33. Rodewald HR, Kretzschmar K, Swat W, Takeda S. Intrathymically expressed c-kit ligand (stem cell factor) is a major factor driving expansion of very immature thymocytes in vivo. Immunity 1995; 3:13-9.
34. Bene MC, Castoldi C, Knapp W, et al. Proposal for the immunological classification of acute leukemias. Leukemia 1995; 9:1783-6.
35. van Dongen JJM. Proposals for immunological classification of acute leukemias. Leukemia 1995; 9:2149-50.